COVID-19 vaccination in Nepal

Last updated

COVID-19 vaccination programme
AstraZeneca (Indian version) 2021 cropped.jpg
Oxford–AstraZeneca (Covishied), the most commonly used vaccine in Nepal [1]
Date27 January 2021 (2021-01-27) – present
(348 days ago)
Location Nepal
Cause COVID-19 pandemic in Nepal
TargetImmunisation of Nepalese against COVID-19
Organised by Government of Nepal
Participants
  • 1,51,72,527 people with at least one dose administered
  • 1,12,32,683 people have been fully vaccinated
Outcome
  • 51% of the Nepalese population has received at least one dose.
  • 38% of Nepalese population has received full doses
Website www.mohp.gov.np
vaccine.mohp.gov.np

Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February. [2] In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said “We will export vaccines taking into account the domestic demand.” [3] By late July, there was still uncertainty in Nepal over when SII would deliver the vaccines that were purchased, although Prime Minister Narendra Modi said India would "resume the supply of vaccines soon." [4]

Contents

Nepal approved China's Sinopharm BIBP vaccine (BBIBP-CorV) for emergency use on 15 February. The first doses arrived in Nepal on 29 March. [2] By July, China, had provided 1.8 million doses of the Sinopharm BIBP vaccine under grant assistance, and committed to providing another 1.6 million doses. Separately, the government purchased 4 million doses in June for which delivery was expected to be complete in a few days and was expected to purchase another 6 million doses in July. [5]

About 1.52 million doses of single dose Janssen vaccine (Johnson & Johnson) arrived on July as aid from the United States. [6] Similarly, Ambassador Berry assured that the U.S. had prioritized additional vaccine assistance to Nepal realizing the need. [7] Nepal on 25 October 2021 received 100,620 doses of Pfizer-BioNtech COVID-19 vaccine provided by the United States through COVAX. [8]

Nepal is set to receive 1.6 million doses of single dose Oxford AstraZeneca as aid from Japan. [9] Nepal has requested additional 3 lakhs vaccine dosage from Bhutan which is under consideration. [10]

Different stages

The campaign was launched with the 1 million doses initial doses of the Oxford-Astrazeneca vaccine. At that time, the virus had claimed 2,017 lives and infected 270,092 across the country. Around 430,000 frontline workers–health workers, supporting staffers at health facilities, female community health volunteers, security personnel, sanitation workers, elderly people living in care homes, and prisoners–were listed as priority groups for vaccination. After the first round of the first phase was completed, the government said journalists and diplomatic staff could take the jabs. When the government announced that the first phase was completed on 5 March, as many as 438,000 had received their first dose. [2]

The day the second phase of vaccination was started 348,000 doses of Covishield arrived in Nepal under the World Health Organisation-backed COVAX facility. The government said all the citizens above 65 years of age would be inoculated. The public response was quite encouraging. In the second phase, around 1.3 million people were inoculated across the country. [11]

Nepal became the first country in the Asia Pacific to provide vaccines to the refugees. It was started in March 2021. [12]

Vaccines in order

Currently, the vaccines approved by government of Nepal for emergency use are:

VaccineCountry of manufactureApprovalDeploymentVaccination status
First doseFully vaccinated
Oxford–AstraZeneca
  • India (Covishield)
  • Japan
  • Sweden
Green check.svg Yes [13] Green check.svg Yes18,68,4257,24,992
Janssen USAGreen check.svg Yes [14] Green check.svg Yes12,62,918 [15]
Sinopharm BIBP ChinaGreen check.svg Yes [16] Green check.svg Yes25,74,5377,38,324
Pfizer–BioNTech USAGreen check.svg Yes [17] Green check.svg Yes
Moderna COVID-19 vaccine USAGreen check.svg Yes [18] Green check.svg Yes
Covaxin IndiaGreen check.svg Yes [19] Dark Red x.svg No
Sputnik V RussiaGreen check.svg Yes [20] Dark Red x.svg No
CoronaVac ChinaGreen check.svg Yes [21] Dark Red x.svg No

Related Research Articles

Vaccine diplomacy Use of vaccines

Vaccine diplomacy, a form of medical diplomacy, is the use of vaccines to improve a country's diplomatic relationship and influence of other countries. Meanwhile, vaccine diplomacy also "means a set of diplomatic measures taken to ensure access to the best practices in the development of potential vaccines, to enhance bilateral and/or multilateral cooperation between countries in conducting joint R&D, and, in the case of the announcement of production, to ensure the signing of a contract for the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part in the distribution of the smallpox vaccine.

COVAX Initiative to provide COVID-19 vaccines

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). It is one of the three pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well logistics, country readiness and in-country delivery.

Sinopharm BIBP COVID-19 vaccine Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in India Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 4 January 2022, India has administered over 1.52 billion doses overall, including first and second doses of the currently-approved vaccines. In India, 87% of the eligible population has received at least one shot, and 62% of the eligible population is fully vaccinated.

COVID-19 vaccination in Albania

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. In June 2021, the World Health Organization predicted that 47 of Africa's 54 nations would fall short of the aim of vaccinating 10% of their people by September 2021. In June, Africa accounted for fewer than 1% of worldwide vaccine doses delivered.

COVID-19 vaccination in Bhutan

Bhutan has promised a free COVID-19 vaccination to all of its citizens, both inside and outside the country. It started mass vaccinations on 27 March 2021.

COVID-19 vaccination in Vietnam Plan to immunize against COVID-19 in Vietnam

The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Indonesia

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks third in Asia and fifth in the world.

COVID-19 vaccination in Bangladesh Immunisation programme against COVID-19 in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Sri Lanka Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination in the United Arab Emirates is an ongoing mass immunization campaign, in response to the ongoing pandemic.

References

  1. "COVID-19 Situation Report - 26 August 2021" (PDF).
  2. 1 2 3 "Nepal's vaccination status". The Kathmandu Post. 12 May 2021.
  3. "As Nepal struggles to continue vaccine drive, India denies export restrictions". kathmandupost.com. Retrieved 29 July 2021.
  4. "In a telephone conversation to congratulate Deuba, Indian Prime Minister Modi assures vaccine supply". kathmandupost.com. Retrieved 4 August 2021.
  5. "Deal to buy 6 million vaccine doses from China likely soon, officials say". kathmandupost.com. Retrieved 29 July 2021.
  6. "1.5 million doses of J&J vaccine arrive in Nepal". kathmandupost.com. Retrieved 4 August 2021.
  7. "U.S. Ambassador Berry pays courtesy call on Home Minister Khand". Khabarhub. Retrieved 4 August 2021.
  8. "Over 100,000 doses of Pfizer-BioNtech vaccine arrive in Nepal". kathmandupost.com. Retrieved 26 October 2021.
  9. "Nepal to get 1.6 million AstraZeneca vaccine doses as donation from Japan". South Asia Monitor. Retrieved 4 August 2021.
  10. "Nepal seeks Covid-19 vaccine doses from Bhutan". kathmandupost.com. Retrieved 4 August 2021.
  11. "Nepal's vaccination status". kathmandupost.com. Retrieved 7 July 2021.
  12. Refugees, United Nations High Commissioner for. "Nepal becomes first country in Asia Pacific to vaccinate refugees against COVID-19". UNHCR. Retrieved 25 October 2021.
  13. "Nepal approves AstraZeneca COVID vaccine for emergency use – government statement". Reuters. 15 January 2021. Retrieved 31 May 2021.
  14. "1.5 million doses of J&J vaccine arrive in Nepal". The Kathmandu Post. Retrieved 12 July 2021.
  15. "Situation Report" (PDF). Ministry of Health and Population.
  16. "China's Shinopharm vaccine gets emergency use authorisation in Nepal". The Kathmandu Post. Retrieved 31 May 2021.
  17. "US donated Pfizer vaccine arrives in Nepal". 25 October 2021.
  18. "Nepal receives 1,965,600 doses of Moderna vaccine from COVAX".
  19. "Nepal becomes third country to give emergency nod to Indian vaccine COVAXIN". Reuters. 19 March 2021. Retrieved 31 May 2021.
  20. "Nepal approves Russia's Sputnik V COVID-19 vaccine". Reuters . 20 April 2021. Retrieved 31 May 2021.
  21. "Nepal gives emergency use approval to China's Sinovac Covid-19 vaccine". kathmandupost.com. Retrieved 7 June 2021.